AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs

AbbVie’s largest deal in more than half a decade adds a group of immune disease medications — among them a Dupixent competitor — the company believes to have “mega-blockbuster” sales potential.

https://www.biopharmadive.com/news/abbvie-apogee-acquire-zumilokibart-eczema-drugs/823353/

#TopNews #News #AbbVie #Apogee #Apogees

Word Search Puzzle 746

Word List : #areolae #thuggish #bradawl #odometer #obtuser #apogees #orache #minutial #demote #nunning #incases #manyness #coalier #epural #verdi #cytocide #lifedrop #danio

Kara Finance